Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Mesa Laboratories (MLAB) EBITDA (2016 - 2025)

Historic EBITDA for Mesa Laboratories (MLAB) over the last 16 years, with Q4 2025 value amounting to $8.0 million.

  • Mesa Laboratories' EBITDA rose 3799.97% to $8.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $17.2 million, marking a year-over-year increase of 10672.03%. This contributed to the annual value of $16.3 million for FY2025, which is 10600.42% up from last year.
  • Mesa Laboratories' EBITDA amounted to $8.0 million in Q4 2025, which was up 3799.97% from $4.7 million recorded in Q3 2025.
  • Over the past 5 years, Mesa Laboratories' EBITDA peaked at $8.0 million during Q4 2025, and registered a low of -$271.3 million during Q1 2024.
  • Over the past 5 years, Mesa Laboratories' median EBITDA value was $3.1 million (recorded in 2021), while the average stood at -$11.4 million.
  • Within the past 5 years, the most significant YoY rise in Mesa Laboratories' EBITDA was 872537.31% (2024), while the steepest drop was 5257272.73% (2024).
  • Over the past 5 years, Mesa Laboratories' EBITDA (Quarter) stood at -$2.5 million in 2021, then skyrocketed by 235.43% to $3.4 million in 2022, then crashed by 101.97% to -$67000.0 in 2023, then skyrocketed by 8725.37% to $5.8 million in 2024, then soared by 38.0% to $8.0 million in 2025.
  • Its last three reported values are $8.0 million in Q4 2025, $4.7 million for Q3 2025, and $3.1 million during Q2 2025.